alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. - Wikidata - wikimedia - TriplyDB

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.

http://www.wikidata.org/entity/Q33766805

about

Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury Development of prognostic models for patients with traumatic brain injury: a systematic review Mitochondrial injury after mechanical stretch of cortical neurons in vitro: biomarkers of apoptosis and selective peroxidation of anionic phospholipids Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study Age-related intraneuronal elevation of αII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3×Tg-AD mice What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment Potential Blood-based Biomarkers for Concussion.Neuroprotective effects of selective N-type VGCC blockade on stretch-injury-induced calcium dynamics in cortical neurons αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.Sialoglycosylation of RBC in visceral leishmaniasis leads to enhanced oxidative stress, calpain-induced fragmentation of spectrin and hemolysis.A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.Blood-based diagnostics of traumatic brain injuries.Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury.Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes Therapy development for diffuse axonal injury.Role of α-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury.Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases Calpain as a therapeutic target in traumatic brain injury.Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.The role of calpains in traumatic brain injury.Monitoring biomarkers of cellular injury and death in acute brain injury.The role of excitotoxic programmed necrosis in acute brain injury.Biomarkers in traumatic brain injury: a review.Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.Proteomics analysis after traumatic brain injury in rats: the search for potential biomarkers.Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats.Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma.Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.Diffuse Axonal Injury and Oxidative Stress: A Comprehensive Review.

P2860

Q24626804-B35E48F8-F030-4416-A619-A40F6A2C2BB5 Q26765302-E3E07E67-FC87-49F6-8BEB-000E8725FA4C Q28397584-9AB8B973-7AB1-46EB-A502-4AD1E044EF6C Q28535264-2377802E-591D-416E-98C4-6ADA52D99CC2 Q28728312-CD315104-B0B6-45BE-B195-8087BC120812 Q30959630-1B561A4D-86C3-4223-9D9A-715E3D066936 Q31119100-3BB23363-94C1-4FC8-9BF8-437470F217FE Q33666627-793935DE-B4A3-485D-89E4-240326798346 Q34142573-5A3E4EDF-D56A-4E60-9B22-16168CC7337F Q34364823-68AAA96F-5D3E-43DA-B3C3-1FA8765FFE8C Q34378362-9EEA7F83-6227-4AC5-8D88-686CB818E9D0 Q34619162-5419B899-9FB3-4813-A2CB-2E24E3C0F8BB Q34627266-E162EACC-25AB-4244-BEF4-02C6B98CF1A1 Q34714369-FB1BBE7D-C665-45F8-814F-55F08C4B1A06 Q35131093-208B408E-335C-43A2-AD77-9E3201EC9AD4 Q35252148-9F522CE0-D70B-49F9-B1D4-9D669A2E571F Q35547433-8DD2464C-FF03-44F6-81C7-07FBF2C34ABC Q35659358-F9335188-5D37-4B8F-9CC3-DB09EA35FFEB Q36079583-E5D200CC-F0C9-4EBE-BB17-8B61D6CC0E97 Q36127362-CE4C00E9-BC9E-4EBB-BEB8-6C9371ECDFDD Q36131599-7C82A73D-7EFA-448E-BE22-8E8EDC128CDC Q36366723-B7C3F150-08F0-4A2A-998C-06C4C8243217 Q36768885-26CF4F86-BCD3-42D5-9AC6-3101DBB799AF Q36824690-E0DC6FEA-9589-4981-8065-4AEF6410EBF3 Q36867723-6E32572A-1F17-4A03-A4B5-D511F541B293 Q37686765-C10BE930-3A4E-4859-A2CE-880E397AAC4B Q38109663-B7EB2ED6-293A-4E24-822F-30E5B35D4CCC Q38181174-2BFD2BE1-114F-4655-88A9-0EE67790E3DD Q38248158-D7D28A62-78C7-464F-B28F-972431EE3EB4 Q38429588-8FC9C1AF-F905-40E1-95B8-1D153CB5E646 Q38623128-907309EC-8E87-4D91-BD7F-8A716A532E2F Q38784171-ECB71264-2044-4F95-8CD6-F203A03A49A1 Q39004631-5358ADFB-71B2-4C6D-9A48-0587BCC14A69 Q41997832-F68F6872-E5CB-4152-A0D4-675EF28F9093 Q42716996-45D7FBF6-6718-4B38-AE5E-012F5A7EAB4B Q42788353-0B175509-0D27-4B68-881D-045D469558EA Q44923505-96B04CDC-D742-4964-B3D9-F8BD71286B13 Q45067173-4356E47F-DAF6-4C71-A113-C675B5E51900 Q45678701-E6691C59-E45B-4A9E-8C1E-9D15594F83E1 Q46247593-E734D76F-ADAC-4465-B1B0-D7704EE8CB16

P2860

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.

http://www.wikidata.org/entity/Q33766805

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@ast

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@en

type

label

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@ast

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@en

prefLabel

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@ast

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@en

P1433

Q33766805-D4E4B762-DCDD-47FD-9119-E83C28D19AE6

P1476

Q33766805-AE1AA202-2E9B-4EFD-BE4F-EE278736A022

P2093

Q33766805-05607D9A-DD26-4B5C-81F4-72EB21735797

Q33766805-2906D1C1-0389-4DF9-A50E-F23FACE8F7C3

Q33766805-3CCF3DA2-22C5-4F84-84AF-083F39B041FA

Q33766805-4C41903A-82C5-4C9A-B522-C573ADC2F5F1

Q33766805-52298C4C-A0B4-4FC0-B290-4798689B513F

Q33766805-74D901FB-25CF-49E5-9965-A973A2B53A1A

Q33766805-7922183B-AF12-425F-A32F-6B17B3DEAB29

Q33766805-A62B0B15-33F9-4D7B-9299-F27316C2126A

Q33766805-A73B112A-B0EB-471C-80CB-9A71278E4C33

Q33766805-C744A48E-388D-43EA-8D6B-F3B36D56F30E

P2860

Q33766805-23A8A73A-3F7D-4593-A075-83FD377DCDE8

Q33766805-29CE09AA-0F62-4D5D-8D12-765DF36FC9A8

Q33766805-2A5DBBF4-95B3-4238-AD35-BF1B99FA165B

Q33766805-5AA0E7FB-9893-40C7-B49D-77936A48A492

Q33766805-73F1149F-EFFF-4C61-870E-D60E338992A5

Q33766805-7566E0C1-0331-4173-8795-1655E5F49807

Q33766805-81B7B111-2FF6-434F-B785-22E2789623F1

Q33766805-94D82A11-90E3-4960-A51E-E03DAB90599E

Q33766805-D478E1A2-D7CA-4496-AE85-D6CE758AF7B7

Q33766805-EB507DFB-5AD2-4440-8E09-609A55CC6BB2

P304

Q33766805-DE767298-7D5A-4AF2-9DC5-F4DDBB7E5BE0

P31

Q33766805-9CBFFCF7-9C8F-44C6-A6D7-CC4E04F2DCBD

P356

Q33766805-7404CEC9-C339-4E9C-9215-8E4BDD810D96

P433

Q33766805-26F2E1B8-1F14-4D39-BFD9-272C31711C92

P478

Q33766805-16A15C4C-827C-4FD6-BD6F-AC31FFCF9632

P50

Q33766805-0754F623-3F3E-44E2-BAD2-78BEE8F269CA

Q33766805-0BCBEA84-B4AD-4430-93E1-F579B969D7EB

Q33766805-39324E75-7D69-4C59-94B8-7208F7B1953E

P577

Q33766805-A92C6454-C0B1-4707-A275-27E57BA67DA9

P5875

Q33766805-274C125B-8674-4B5E-B414-8E640B72C8D3

P698

Q33766805-9FE74791-C3D1-4C79-8BBE-8C128181F0FD

P921

Q33766805-C1BCF214-CCB6-450B-8D6D-F9289B872B0E

Q33766805-DEEDF6AF-2495-4B85-8261-698A2904EF81

P932

Q33766805-31BB3D8A-B4B1-44EC-8212-5FCE642D6852

P356

P1433

Journal of Neurotrauma

P1476

alphaII-Spectrin breakdown pro ...... severe traumatic brain injury.

@en

P2093

Alex B Valadka

http://www.w3.org/2001/XMLSchema#string

Andrea Gabrielli

http://www.w3.org/2001/XMLSchema#string

Claudia S Robertson

http://www.w3.org/2001/XMLSchema#string

Jason A Demery

http://www.w3.org/2001/XMLSchema#string

Jose A Pineda

http://www.w3.org/2001/XMLSchema#string

Joseph J Tepas

http://www.w3.org/2001/XMLSchema#string

Linda Papa

http://www.w3.org/2001/XMLSchema#string

Ming Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Ronald L Hayes

http://www.w3.org/2001/XMLSchema#string

Shelley C Heaton

http://www.w3.org/2001/XMLSchema#string

P2860

Calpain and caspase: can you tell the difference?

The public health approach to traumatic brain injury: an overview of CDC's research and programs.

Tracking the silent epidemic and educating the public: CDC's traumatic brain injury-associated activities under the TBI Act of 1996 and the Children's Health Act of 2000.

Calpain and synaptic function.

Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis.

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model.

Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma.

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.

P304

471-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/NEU.2008.0657

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

H. Julia Hannay

Gretchen Brophy

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23997547

http://www.w3.org/2001/XMLSchema#string

P698

19206997

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

cerebrospinal fluid

P932

2848834

http://www.w3.org/2001/XMLSchema#string